Heart health/fewer heart attacks from Contrave, a weight loss drug?


cannon Interesting data from an interim look at Contrave (bupropion plus naltrexone). In a follow up study of 8,910 people, not only did they lose weight, but they had fewer heart attacks. This is an interim analysis and controversy follows the release as it was seen with only 25% of the study finished.

What is very very interesting is that researchers thought that this benefit was a direct effect of the two-drug combination. More to follow as always... 

Visit www.fda.gov for more from their perspective and the company name is Orexigen. I will be putting Contrave in the upcoming Essential Guide to Prescription Drugs. Feel free to visit my author page on amazon: https://www.amazon.com/author/jamesrybacki

This website is not intended as medical advice, and you should consult your doctor before changing or adding any medicines or vitamins to those you may now be taking and about applying any strategies BEFORE you adopt any approach in this report. While diligent care has been taken to ensure the accuracy of the information provided during the preparation of this edition, no claim is made that all known actions, uses or side effects, strategies for cost containment, targets or cholesterol pathways are included in this report. The accuracy and currentness of information are ever subject to change relative to new guidelines, new information derived from drug research, development and general usage.